Introduction
Over the last several years, genome-wide association studies (GWAS) have become one of the most important and popular tools in the process of gene mapping. While at the beginning their inherent challenges from their costs, data management, cleaning and analysis prohibited their large-scale use, GWAS are now generally feasible for most diseases and phenotypes, and have been extensively used by the scientific community. They have led to the identification of many novel associations between genetic loci and complex diseases/phenotypes, which have been replicated consistently and reliably in other studies.
However, despite their success in terms of the discovery of novel genetic associations, GWAS have not identified the genetic associations that explain the majority of the expected genetic heritabilities for most traits. For example, genes related to height found by GWAS so far only explain 6-7% of the total variability in height [1] , even though genetic heritability is believed to be between 70 and 90%. Therefore, there has been a concerted effort to utilize all available GWAS for a particular phenotype of interest by doing a large-scale meta-analysis in order to maximize the statistical power to identify novel disease loci.
Of course, a meta-analysis of several studies at a genome-wide level raises some statistical issues. One is that the same markers should be genotyped in all studies, which is not the case in most scenarios, since different genotyping platforms are likely to have been used in each study. This problem can be addressed by using imputation techniques. Imputation algorithms infer the genotypes at the untyped marker loci using both the linkage disequilibrium (LD) information about the genomic region from a reference population, e.g. HapMap, or other genotypes at the typed marker loci in the same LD region in the same study. Currently, there are a number of efficient imputation approaches [2] [3] [4] . For the purpose of this paper, we assume that the same single nucleotide polymorphisms (SNPs) are genotyped in all studies of the meta-analysis.
A second issue is the genetic and phenotypic heterogeneity introduced by the inclusion of different studies into the meta-analysis. Typically, large-scale studies in such meta-analysis projects have been collected at different time points and locations. At the same time, the ascertainment condition defined by phenotype often varies. Since it is very difficult to identify all differences between studies and account for them in the analysis, the meta-analysis results become susceptible to confounding and their control is a major issue in the analysis. The total sample size in a large-scale meta-analysis project can easily exceed more than 10 or 20 thousand individuals, and for such sample sizes, even small imbalances due to population structure can result in a systematic bias in the results of the association tests [5] . While there are several approaches to adjust for population structure in unrelated samples, none of the approaches are able to achieve the complete robustness of family-based design. For example, the differential level of population structure along the genome or its complicated structure can violate the validity of the statistic [6] . For each approach, examples have been reported in the literature in which the approach fails to adjust correctly, and provides either false positive or false negative results [7] [8] [9] [10] .
Here we propose a new method for the meta-analysis of GWAS that combines both family-based and unrelated samples with rank-based statistics. Other methods such as genomic control and EIGENSTRAT can be sensitive to confounding due to population admixture or stratification for some scenarios. However, the proposed approach for the meta-analysis that consists of both family-based and unrelated samples is completely robust in the sense that the type-1 error does not increase under violations of the model. At the same time, to prevent the proposed method from losing some efficiency, both a principal component analysis (PCA) and linear mixed model are applied. Because PCA and linear mixed model are not necessary for the complete robustness against any confounding, they can be selectively utilized to increase the efficiency for meta-analysis. Using simulation studies, the power and the robustness of the new approach is assessed and compared to standard meta-analysis methods. We illustrate the approach by an application to Alzheimer's disease.
Methods
For simplicity, we assume that all studies that are included in the meta-analysis, regardless of whether samples are family-based or unrelated, have the same phenotypic ascertainment condition. If the phenotypic ascertainment condition is different, the inference by pooled samples can generate substantial false negative results and stratified analysis for each study has to be applied. Depending on the phenotype of interest, the test statistics can be specified so that binary traits, quantitative traits, multivariate traits or time-to-onset can be tested for association with a genetic marker locus [11] [12] [13] [14] .
Since, as we will see below, the proposed meta-analysis approach inherits the complete robustness of family-based samples against population structure, a pooled meta-analysis where all subjects from the studies are incorporated to a single statistic becomes feasible. The principle that guards the proposed meta-analysis method against genetic confounding also protects it against potential confounding due to study heterogeneity. For the proposed method, first, the population structure between or within studies is adjusted with the eigenvectors from PCA and the linear mixed model with the estimated PC scores as covariates is applied to each study. Second, the distribution-based p values from each study are transformed to the rank-statistic [6, 15] and combined to form an overall statistic. It should be noted that the first step is conducted to maximize the statistical power because the rankstatistic in the second step by itself can lose the efficiency without the first step, even though it always guarantees the robustness against the presence of population structure. The details for each step will be provided in the following subsection.
We assume that K GWAS with m SNPs are combined for meta-analysis. In order to keep the notation simple, we assume here that all related subjects are trios, i.e. for each study subject, its genotype/phenotype and the parental genotype/phenotype are known. The same statistics simply extend to large pedigrees. There is a large amount of correlations between family members in a large pedigree and the power improvement for the proposed method becomes larger compared to our previous suggestions [6, 15] . If the k -th study subjects are recruited as part of the familybased design, we let the genotype of the i -th marker locus in the offspring of the j -th trio be x j , ik and the phenotype be y j , k . The subject's parental genotypes and phenotypes are denoted by p 1 j , ik ( p 2 j , ik ) and q 1 j , ik ( q 2 j , ik ), respectively. In the families for which the parental information is missing and paired (or more) sibling studies are available without parental information, the parental genotypes can be replaced by the sufficient statistic for pedigrees [16] .
Within-Family Component and Between-Family Component
In the subject of the family-based samples, the information about the genetic association can be partitioned at the i -th marker locus into the within-family component and the between-family component [17] . At the within-family level, the evidence for association between the i -th marker and the phenotype of interest is summarized by the statistic FBAT i that is computed based on the subject's genotype, conditioning on its phenotype and the parental genotypes. The statistics for the within-family level are robust against the population structure. However, the information about the association at the between-family level is sensitive to the population structure as in the statistic for unrelated samples. Therefore, the information about the association at the between-family level is directly included into test statistic T i for unrelated samples, using offspring's phenotype and its expected genotype which is calculated by Mendelian transmission from the parents to the offspring. This utilization of the proband's phenotype and expected genotype is equivalent to the construction of a VanSteen-type test statistic that is statistically independent of the FBAT statistic under the null hypothesis [12, 18, 19] . We will denote both the unrelated samples and the between-family component by the population-based component in the remainder of this paper.
Principal Component Analysis and Linear Mixed Model
We provide a new method to adjust population stratification in related subjects by extending the EIGENSTRAT approach [9] . However, this approach can also be applied to the populationbased component for T i . Parents in each trio contain the whole information for population structure because the genotypes of nonfounder are transmitted from the founder with Mendelian transmission. We consider only parents, and the computational intensity has been largely improved without any loss of information. Also inclusion of nonfounder for PCA can make spurious PC scores that do not reflect the true underlying population stratification [20] . In the first step, we select/calculate the genotypes/ sufficient statistic for parents and they are used to estimate the correlation matrix between individuals as follows:
• For each trio, only parental genotypes from each family are selected to calculate the correlation matrix. If parental genotypes are unknown, the expectations of sufficient statistics (see Rabinowitz and Laird [16] ) are utilized.
• PCA is applied to the correlation matrix calculated from the selected genotypes/expectation of the sufficient statistics by the same way as EIGENSTRAT.
• From the PCA, L eigenvectors corresponding to the top large L eigenvalues are considered to adjust the population stratification. L can be decided by considering the relative proportion of each eigenvalue to the total variability or Tracy-Widom statistic [21] . The effect of misspecified L has been shown in the literature [9] .
We let pc 1 jl , k and pc 2 jl , k be the l -th PC scores for the parents and pc 3 jl , k for offspring, where l = 1, ..., L . pc 1 jl , k and pc 2 jl , k are calculated from the correlation matrix, and pc 3 jl , k is calculated as 0.5( pc 1 jl , k + pc 2 jl , k ) because the common diseases are generated by several different genes, and recombination and Mendelian transmission make this relationship preserved. For the j -th trio at the i -th SNP we let
We apply the weighted linear regression with correlation matrix R [22] as follows:
1 , 
our final model for trio in the k -th study is
,
If there are monozygotic twins, the linear regression of X j , ik on PC scores cannot be conducted. Thus a single individual of each monozygotic twin should be used for the regression but the residual is used for both of each monozygotic twin for the regression of Y j , k . For V we need to consider the polygenic effects and common environment effects, and it can be achieved with the proposed linear mixed model (see Appendix). We denote the variance from the polygenic effects and common environment effects by g 2 and c 2 respectively. If the genotypes of each marker are not available, they can be imputed with Hidden Markov model [23] or Bayesian approach [24] , and then the proposed method can be applied.
Construction of an Overall Association
The proposed PCA-based methods can be violated if the level of population structure varies along the genomic region as was shown for EIGENSTRAT in the literature [6] . In this reason we extend the proposed method to the hybrid analysis [6] in order to construct an overall association test for the entire pooled/mixed sample that is robust against confounding due to population structure or study heterogeneity. For the population-based component, the proposed PCA and linear mixed model are applied to the population-based component for T i across all studies in this step and FBAT i is calculated by using within-family components. It should be noted that either logistic regression or linear mixed model for T i can be chosen depending on the ascertainment condition. Then we obtain the Z-statistic that corresponds to the p values of FBAT i and T i . pT i denotes the rank-based p value of the genotype coefficient for T i that is constructed as follows: if the absolute value of T i is the o -th ordered among the m SNPs, the rank-based p value, pT i , for T i , is defined as
where ␦ indicates the tuning parameter and ␦ = 0.7 is recommended for the robustness of the proposed p value in 500K GWAS [6] . We denote pFBAT i as a distribution-based p value of FBAT i for the i -th marker. For pFBAT i , we use the one-tailed p value with the direction of T i to improve the statistical efficiency. If the number of markers whose T i 's are larger than or equal to T i is smaller than m /2, then the one-tailed test for positive direction is applied to FBAT i and otherwise the one-tailed test for negative direction is applied. We let Z p and ⌽ ( ؒ ) be the p -th quantile and the cumulative normal distribution of the standard normal distribution, respectively. Then, based on the statistical independence of FBA-T i and T i [12] , we can obtain the following overall association test for the meta-analysis , Z i , at locus i for the pooled samples by combining both Z-statistics in a weighted sum:
where w 2 FBAT + w 2 T = 1 and w FBAT Z pFBAT i + w T Z pT i ϳ N (0, 1) under the null hypothesis. The optimal w FBAT and w T for continuous and binary trait are discussed in our parallel paper [15] , and will be used for the proposed method.
As outlined in our parallel paper [6, 15] for family-based association analysis, the overall association test for the meta-analysis will maintain the type-1 error in the absence and presence of systematic confounding as long as the assumption of Mendelian transmission in the family-based studies is preserved under the null hypothesis. The rank-based p values from the population components are always uniformly distributed along the whole genomes and FBAT i are robust to the population structure. Also, because the population-based components and within-family components are independent, our overall statistic provides the valid type-1 error rate at the significance level ␣ under the absence of the genetic effect [6] because .
Depending on the heterogeneity of study design, the metaanalysis using stratified analysis for each study can be conducted to minimize the type-2 error. We call this meta-analysis using unpooled data. We denote pFBAT ik as a distribution-based p value of FBAT for the i -th marker when the k -th study is family based. If the k -th study uses the population-based component from either the family-based or unrelated samples, the p value pT ik denotes the rank-based p value of the genotype coefficient for T ik . Then, our overall Z-statistics is 1 2 , ,
where u 1 indicates the studies using family sample, and u 2 indicates the studies using population-based components. It can be easily shown by mathematical induction that the independence of statistics from each study at the i -th marker provides 1 2 , , 1 1 .
It should be noted that this is also preserved even when there is heterogeneity of studies, or non-normality of phenotypes.
Results

Simulation Studies
The type-1 error and power of the proposed familybased association test was assessed in the absence and in the presence of population stratification. For simplicity, in the simulation studies we consider nuclear families for which both parental genotypes and phenotypes are either known or unknown. To alleviate the computational intensity, T i for 100 K markers are calculated under null hypothesis, and they are used to get the rank for pT i in 100,000 replicates for empirical type-1 error and 5,000 replicates for empirical power.
Assuming Hardy-Weinberg equilibrium, the parental genotypes are generated by drawing from Bernoulli distribution defined by the allele frequencies. The offspring genotypes are obtained by simulated Mendelian transmissions from the parents to the offspring. The phenotypes for each individual are decided by summing the phenotypic mean, , polygenic effect, common environmental effect, main genetic effect and random error. The polygenic effect is independently generated from N (0, g 2 ) for parents, and their average is combined with the value randomly sampled from N (0, 1/2 g 2 ) for offspring. For the main genetic effect, the genetic effect size parameter a is multiplied with the number of disease allele of each subject. For instance, the main genetic effect for the subject with homozygous disease genotype is 2 a . The random error is generated from N (0, e 2 = 1). Under the null hypothesis of no association, the coefficient a will be set to 0. For scenarios in which population stratification is present, we assume that the population stratification is created by the presence of 2 subpopulations and each parent is assigned to either of the 2 subpopulations with 50% probability. for parents is either 0 or 0.4 depending on On the Meta-Analysis of Genome-Wide Association Studies Hum Hered 2012;73: [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] 39 the subpopulation and their average is used for offspring. The other effects for phenotype are sampled in the same way as in the absence of population stratification. The allele frequencies for each marker in the two subpopulations are generated by the Balding-Nichols model [25] . That is, for each marker, the allele frequency, q , in an ancestral population is generated from a uniform distribution between 0.1 and 0.9, U (0.1, 0.9). Then, if we let F ST be the Wright's measure of population subdivision, the marker allele frequencies for the two subpopulations are independently sampled from the beta distributions 2 indicates the rank-based p value from the linear mixed model for conditional mean model without adjustment of population stratification, and simple linear model without adjustment of population stratification is applied in pT 3 where the latter is equivalent to our recent works [6, 15] . Each rank-based p value is combined with pFBAT with optimal weights. Z 1 , Z 2 and Z 3 correspond to the overall p values that combine pFBAT with pT 1 , pT 2 and pT 3 , respectively. The proposed PCA method and linear mixed model are directly applied to whole families without transformation to rank-statistic and they are denoted as POP . POP is based on the Wald test and it is approximately equal to the variance component model approaches [27, 28] . We assume that parental phenotype/genotypes are known and 500 nuclear families with N off offspring are available for each replicate. We assume that c 2 = g 2 = 0.3. Table 1 shows the empirical type-1 error estimates for the proposed linear mixed model with or without adjustment of population stratification in the absence ( F ST = 0.00) and presence of the population stratification for 3 different F ST ( F ST = 0.001, 0.005 and 0.01). The results from POP do not provide any evidence for a departure of the empirical type-1 error estimates, both in the absence and presence of population stratification. That is, the proposed PCA method adjusts the population stratification and the linear mixed model fits the correlation of the family members well. Also all of Z 1 , Z 2 and Z 3 preserve the ␣ level and we confirm that the rank-based p value is a single requirement to provide the validity under the presence of population stratification and misspecified covariance matrix.
In the next set of simulation studies, we assess the empirical power over the different nuclear family structures. Under the assumption of an additive disease model for a quantitative trait, the genetic effect, a , is given as a function of the heritability attributable to main genetic effect, h 2 , the disease allele frequency, p D , and the phenotypic variance, 2 = c 2 + g 2 + e 2 , by:
where h 2 indicates the heritability attributable to the main genetic effect. We assume that p D = 0.1 and e 2 = 1. We assume 500 nuclear families available in our simulations. Table 2 shows the empirical power estimates from 5,000 replicates when parental genotypes/phenotypes are known. The results show that POP is the most powerful under both absence and presence of population stratification, followed by Z 1 . However, their difference is usually very small. FBAT does not use the between-family components and it is the least informative. The results indicate that the hybrid analysis [6, 15] can be improved when the linear model with appropriate correlation structure is applied to conditional mean model and the population stratification is adjusted. For the application of the linear mixed model to the between-family component of the subjects from the family-based designs, the expected ge- notypes instead of the observed genotypes for offspring are used for the computation of the test statistic T i . For the between-family component the phenotypic variance of parents, Var( q 1 j , ik ͉ p 1 j , ik ), is different from the phenotypic variance of the subjects from the family-based design, Var( y j , k ͉ p 1 j , ik , p 2 j , ik ), but our linear mixed model to the between-family component assumes that both are same. The test statistic is generally the most efficient when the variance/covariance structure is correctly specified and it may explain the reason for the power loss of Z 1 compared to POP .
Power Analysis in an Unpooled Meta-Analysis
We calculate the effect of rank-based p-value transformation on the power. The empirical power at 0.05 genome-wide significance level is calculated from 10,000 replicates for 500K GWAS under Bonferroni correction. We consider the meta-analysis in which one family-based and one unrelated sample are combined, and one familybased and two unrelated samples are combined. When two unrelated samples are used, their sample sizes are assumed to be equal. 1,000 trios for family-based samples are generated with parental phenotypes unknown for both cases. The results from each study are combined with Liptak method using the optimal weights. POP is the empirical power estimates when the linear regression is applied to both family-based and unrelated samples. For other statistics, family-based samples are split to between-family and within-family components, and then FBAT for within-family component is calculated. For between-family component, the linear regression is used and it is combined with FBAT . While the distributionbased p value from between-family component and unrelated samples is combined with FBAT in NONRANK , the rank-based p value for between-family component and unrelated samples is combined in RANK .
For our empirical power estimates, we assume that h 2 = 0.005 and c 2 + g 2 + e 2 = 1 under the absence of population structure. Because we assume that the parental phenotype is unknown, the identification of c 2 , g 2 and e 2 is not required. For disease model, we assume that p D = 0.1 and the genetic effect a is calculated in the same way as in the simulation study for table 2 . Table 3 shows the empirical power estimates for each meta-analysis. The results show that POP is always the most efficient, followed by NONRANK while both are virtually equal. RANK is always least efficient. However the power loss is negligible if three or more studies are combined, even when unrelated samples have much larger sample size, compared to family-based design. If the sample sizes for family-based and unrelated samples are not highly different, the power loss of RANK is also very small.
Also we consider the meta-analysis with only unrelated samples as an extreme case. In figure 1 , we assume the meta-analysis without family-based samples and it shows the relative power of rank-based p value compared to the distribution-based p value. We assume the metaanalysis with 2, 4, 10 and 20 studies, and their Z-statistics for each study are simply generated from N (0.05, 1). Then their p values using both distribution-based and rankbased approaches are calculated respectively, and the Liptak method is applied to combine the p values. We assume GWAS with 1,000 SNPs or 10,000 SNPs, and the relative efficiencies of empirical powers are calculated from 2,000,000 replicates at the genome-wide ␣ = 0.05 level. Figure 1 shows that the relative power of the rankbased p values is proportional to the number of studies and SNPs. Our results confirm that the proposed metaanalysis can have more than 90% relative efficiency with more than two GWAS for large-scale genome-wide metaassociation analysis. As a result, because RANK is a unique choice that preserves the complete robustness to any type of violations, such as non-normality, population stratification, etc., we recommend using the rank-based p value for unrelated samples.
Application to Alzheimer Studies
Late-onset Alzheimer's disease is a progressive and fatal brain disease. During the last 30 years, people have tried to localize the Alzheimer's disease susceptibility genes, but except for APOE those efforts have mostly led to inconsistent findings, even though Alzheimer's disease is highly inheritable [29] . To overcome this problem, several 500K GWAS [30] [31] [32] [33] have been conducted to identify the causal gene. However, each single GWAS may be under insufficient efficiency and results for each marker need to be confirmed with a robust approach.
In our analysis, we applied the proposed method to one family-based design and the meta-analysis is performed with two additional case-control designs. The family sample was collected as part of the National Institute of Mental Health Genetics Initiative Study and it is denoted as NIMH. For meta-analysis one case-control sample was collected by the Translational Genomics Research Institute and the other case-control sample was collected by GlaxoSmithKline. We denote the former and the latter by TGEN [33] and GSK [32] , respectively. Each of these three studies performed whole genome association analysis using 500,668 SNPs on the GeneChip Human Mapping 500K Array Set (Affymetrix, Santa Clara, Calif., USA). For our analysis, if the minor allele frequency is less than 0.05, or the p value from Hardy-Weinberg Emp irical power is estimated with 10,000 replicates at the 0.05 genome-wide significance level. The multiple testing problem is addressed with Bonferroni correction. We assume 1,000 trios available for family-based samples with parental phenotypes unknown. N denotes the sample size for each unrelated sample. POP indicates the empirical power estimates when a simple linear regression is applied to trio and unrelated samples, and the results from each study are combined with Liptak's method with the optimal weights. For NORANK and RANK, trio data are split to between-family and within-family components, and then T and FBAT are calculated respectively. While the distribution-based p values for between-family component and unrelated samples are combined with FBAT with Liptak's method in NONRANK, the rank-based p values for between-family component and unrelated samples are combined in RANK. proportion test is less than 0.0001, these SNPs are excluded from the analysis. The analysis was conducted in the Linux system with 2,412.309 cpu MHz, and the computation took around one week with a single node. The programs for PCA were developed with C++ and will be included in PBAT software. NIMH consists of two populations, European American and African American, and we can expect that there may be population stratification. FBAT is applied to the within-family component of NIMH. The proposed PCA method is conducted to adjust population stratification and the linear regression using PC scores as covariates is applied to the between-family component. It was empirically shown that through the analysis of Phase II HapMap the differential level of linkage disequilibrium does not significantly affect the results [9] and we use all SNPs that passed the quality control. Then the rank-based p value for between-family component and the exact p values of FBAT are combined with Liptak's method. Figure 2 shows the PC scores for NIMH. The first PC score is plotted against the second PC score. We found that two PC scores explained more than 90% of the total variability and chose two PC scores for the analysis. 1,376 individuals from 410 families are self-reported European ancestry and they are labelled with 1 in figure 2 . Fiftyeight individuals from 24 families were of African descent and they are labelled with 2. The results show that the proposed method completely identifies African descent and European ancestry, and it seems there may be two subgroups in European ancestry. Table 4 shows the results from NIMH. 360,742 SNPs in NIMH after quality control are analyzed and the 0.05 genome-wide significance level is 1.386 ! 10 -7
. We have two genome-wide significant SNPs. The most significant and the second genome-wide significant SNPs are SNP1 and SNP2, respectively. In our paper, their rs numbers are not shown but they will be updated with additional results in our follow-up studies. Table 5 shows the results from our meta-analysis. The SNPs from SNP1 to SNP20 in PC2   2 2 2  2  2 2  2  2  2 2  2 2 2 2 2 2  2 2  2   2   2   2   2  2 2 2 2  2 2  2  2  2 2  2 2 2 2 2   2 2  2 2  2 2 2 2  2 2  2 2 2 2 2  2 . Our results show that there are three genomewide significant SNPs, SNP1, SNP21, and SNP2. SNP1 and SNP2 were also significant in table 4 . pT in NIMH in table 5 are different from those in table 4 and it happens that the number of available SNPs in both tables are different.
In particular, table 5 shows that the results from TGEN are inconsistent with the other studies. For example, SNP1 is very significant in NIMH and GSK while it is not in TGEN. At the same time, the allelic direction in TGEN does not correspond to the others. Because SNP1 is associated with APOE that is generally known to be associated with Alzheimer's disease, the systematic heterogeneity for ascertainment condition may exist in TGEN. The insignificance of SNP1 in TGEN can also be explained with this systematic heterogeneity. If we exclude TGEN from our meta-analysis and consider their directions, the p values for SNP2 and SNP21 are 3.82 ! 10 -8 and 1.40 ! 10 -6 , respectively. Thus, SNP2 seems the more promising SNP associated with Alzheimer's disease. This SNP2 is novel and will be verified in the other populations in our follow-up study.
Discussion
In genetic association analysis, it has been known that the presence of population stratification can deteriorate the validity of genetic association and many different methods have been proposed. Under population stratification we can adjust them either by modeling them or by using the robust statistics without any statistical model. We will call the former a model-based approach and the latter a model-free approach. For instance, STRUCTURE and EIGENSTRAT are model-based, and TDT and rankbased p values are model-free approaches. The former can increase the efficiency when the assumed models are correct but otherwise they can lose both efficiency and validity. The model-free approaches are beneficial in terms of validity, but they are less efficient under the general population stratification model. Our recommendation is to use both approaches, such as PCA-based approach and rank-based p value, to improve the efficiency and guarantee the validity.
The rank-based p value also provides the statistical inference robust against the other types of violations, such as non-normality and the existence of the confounders. This is because the rank-based p values over the whole genome are always uniformly distributed. One useful application is for computations in a familybased association analysis. The covariance structure in family-based samples makes the calculation of the test statistics intensive and in this reason the statistical analysis in general pedigree structures has been limited. However, if the distribution-based p values are transformed to the rank-based p value, we can use the simplified covariance structure. For instance, for a large pedigree we can split each large pedigree into several nuclear families and the proposed linear mixed model for nuclear family can be applied. The slight power loss is expected but it is worthwhile to try because we can accelerate the computation.
However, even though the proposed method provides flexibility of a genetic analysis, there are still some limitations. First, the pooled meta-analysis under the presence of heterogeneity in the study can lead to reduced statistical power of our meta-analysis approach even though the rank-based p values enable the meta-analysis using the pooled samples. In situations in which substantial study heterogeneity is present and known prior to the analysis, test statistics should be calculated for each study separately and combined into overall statistics, using Fisher's method of combining p values or the Liptak approaches of weighted Z-statistics [34, 35] . Second, the proposed method requires the independence of each statistic for the complete validity. For instance, some SNPs can be the first ranked for all studies because of population stratification. In this scenario, the final p value becomes 8.9 ! 10 -12 for a meta-analysis using two 500K GWAS. Even though it seems uncommon, it is still possible for ancestry informative markers [36] . To prevent this effect, some modification for the proposed method is necessary for the meta-analysis using unpooled samples while the meta-analysis using pooled samples is always fine. Statistics for case-control designs and between-family component from family-based designs are calculated separately and then combined to calculate the summary statistic, such as weighted Z-score. Then the rank-based p values for the summary statistics are combined with the p values from the within-family components in family-based design. This 'double stratification' can lead to the loss of efficiency, but no alternative has been suggested yet in this scenario. Third, if the number of markers is small compared to the sample size or the amount of heritability, our transformation can deteriorate the efficiency. For instance, when 1,000 SNPs are analyzed as was shown in figure 1 , the power of rankstatistic can decrease to around 80% compared to the distribution-based p value. For such a number of SNPs, some modification is necessary but the power loss may be negligible in most GWAS. In future work, we will investigate these problems and some extensions will be provided.
